LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $497,336 | -19.8% | 8,300 | -3.5% | 0.01% | -21.4% |
| Q2 2023 | $620,060 | +12.4% | 8,600 | +14.7% | 0.01% | 0.0% |
| Q1 2023 | $551,700 | +108502.4% | 7,500 | -1.3% | 0.01% | 0.0% |
| Q4 2022 | $508 | -99.9% | 7,600 | -1.3% | 0.01% | -26.3% |
| Q3 2022 | $663,000 | -13.3% | 7,700 | -6.1% | 0.02% | -5.0% |
| Q2 2022 | $765,000 | -8.1% | 8,200 | +1.2% | 0.02% | 0.0% |
| Q1 2022 | $832,000 | -33.5% | 8,100 | 0.0% | 0.02% | -25.9% |
| Q4 2021 | $1,251,000 | +12.2% | 8,100 | +1.2% | 0.03% | 0.0% |
| Q3 2021 | $1,115,000 | +97.7% | 8,000 | +86.0% | 0.03% | +92.9% |
| Q2 2021 | $564,000 | -14.0% | 4,300 | 0.0% | 0.01% | -17.6% |
| Q1 2021 | $656,000 | +64.8% | 4,300 | +7.5% | 0.02% | +41.7% |
| Q4 2020 | $398,000 | +4.5% | 4,000 | 0.0% | 0.01% | -33.3% |
| Q3 2020 | $381,000 | -14.8% | 4,000 | 0.0% | 0.02% | -33.3% |
| Q2 2020 | $447,000 | +53.6% | 4,000 | 0.0% | 0.03% | +28.6% |
| Q1 2020 | $291,000 | -33.6% | 4,000 | -4.8% | 0.02% | -4.5% |
| Q4 2019 | $438,000 | -4.4% | 4,200 | -8.7% | 0.02% | -8.3% |
| Q3 2019 | $458,000 | -21.0% | 4,600 | -8.0% | 0.02% | -17.2% |
| Q2 2019 | $580,000 | -16.1% | 5,000 | -9.1% | 0.03% | -14.7% |
| Q1 2019 | $691,000 | -9.1% | 5,500 | -1.8% | 0.03% | -20.9% |
| Q4 2018 | $760,000 | -70.2% | 5,600 | -39.8% | 0.04% | -60.6% |
| Q3 2018 | $2,553,000 | +29.7% | 9,300 | -2.1% | 0.11% | +22.5% |
| Q2 2018 | $1,968,000 | +26.7% | 9,500 | +1.1% | 0.09% | +25.4% |
| Q1 2018 | $1,553,000 | +24.6% | 9,400 | +3.3% | 0.07% | +24.6% |
| Q4 2017 | $1,246,000 | +7.7% | 9,100 | +7.1% | 0.06% | +5.6% |
| Q3 2017 | $1,157,000 | +22.2% | 8,500 | +9.0% | 0.05% | +17.4% |
| Q2 2017 | $947,000 | +16.2% | 7,800 | +1.3% | 0.05% | +12.2% |
| Q1 2017 | $815,000 | +5.6% | 7,700 | +1.3% | 0.04% | +2.5% |
| Q4 2016 | $772,000 | -9.9% | 7,600 | -9.5% | 0.04% | -11.1% |
| Q3 2016 | $857,000 | -14.5% | 8,400 | 0.0% | 0.04% | -15.1% |
| Q2 2016 | $1,002,000 | +16.9% | 8,400 | +5.0% | 0.05% | +17.8% |
| Q1 2016 | $857,000 | -1.2% | 8,000 | 0.0% | 0.04% | +2.3% |
| Q4 2015 | $867,000 | +26.6% | 8,000 | 0.0% | 0.04% | +25.7% |
| Q3 2015 | $685,000 | -14.1% | 8,000 | +1.3% | 0.04% | -7.9% |
| Q2 2015 | $797,000 | +32.6% | 7,900 | +1.3% | 0.04% | +31.0% |
| Q1 2015 | $601,000 | +33.0% | 7,800 | -8.2% | 0.03% | +38.1% |
| Q4 2014 | $452,000 | +10.5% | 8,500 | -2.3% | 0.02% | +5.0% |
| Q3 2014 | $409,000 | -31.6% | 8,700 | -9.4% | 0.02% | -28.6% |
| Q2 2014 | $598,000 | -7.4% | 9,600 | 0.0% | 0.03% | -9.7% |
| Q1 2014 | $646,000 | +30.8% | 9,600 | +2.1% | 0.03% | +34.8% |
| Q4 2013 | $494,000 | – | 9,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |